FCPM III SERVICES B.V.
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | ENGN | 9.63M | $65.79M |
 | NAMS | 9.21M | $262.00M |
 | DYN | 5.46M | $69.11M |
 | REPL | 4.16M | $17.42M |
 | ATXS | 4.11M | $29.90M |
 | BCYC | 3.45M | $26.72M |
 | VOR | 380K | $18.50M |
 | RAPT | 344K | $8.88M |
enGene Holdings Inc.
ENGN
Shares Held
9.63M
Value
$65.79M
NewAmsterdam Pharma Company N.V.
NAMS
Shares Held
9.21M
Value
$262.00M
Dyne Therapeutics, Inc.
DYN
Shares Held
5.46M
Value
$69.11M
Replimune Group, Inc.
REPL
Shares Held
4.16M
Value
$17.42M
Astria Therapeutics, Inc.
ATXS
Shares Held
4.11M
Value
$29.90M
Bicycle Therapeutics plc
BCYC
Shares Held
3.45M
Value
$26.72M
Vor Biopharma Inc.
VOR
Shares Held
380K
Value
$18.50M
RAPT Therapeutics, Inc.
RAPT
Shares Held
344K
Value
$8.88M